Clinical trial preparations for the next pandemic

Area of Science:

• Virology
• Epidemiology
• Clinical Trial Design

Background:

• The COVID-19 pandemic highlighted the urgent need for effective antiviral therapeutics.
• Existing clinical trial infrastructure and methodologies require enhancement for rapid pandemic response.

Purpose of the Study:

• To outline a strategic framework for preparing antiviral therapeutics for future pandemics.
• To propose the establishment of a global clinical trial pandemic reserve.

Main Methods:

• Leveraging best practices from the SARS-CoV-2 pandemic for clinical trial design, analysis, and operations.
• Developing continuous treatment and methodology advancements between pandemics.
• Identifying potential antiviral drugs and diagnostic methods proactively.

Main Results:

• A proposed global clinical trial pandemic reserve comprising medical and quantitative professionals.
• Emphasis on large, simple trials, adequate follow-up time, and appropriate efficacy endpoints.
• Incorporation of sophisticated patient accrual models and data-sharing protocols.

Conclusions:

• Proactive preparation, including a dedicated professional reserve and optimized trial methodologies, is crucial for rapid antiviral therapeutic development during pandemics.
• Continuous research and development between pandemics are essential to maintain readiness.
• Enhanced clinical trial strategies, including data sharing, will expedite the delivery of life-saving treatments.